Notably, mutation of PTEN at residue 138 occurs in several tumor [212,213] and inactivates PTEN with loss of the control of Rab7-dependent endosomal degradation of EGFR and consequent uninterrupted growth signaling with important implications for tumor progression [211]. This evidence concerns the gene EGFR and neoplasm.